Erythromycin A enol ether
CAS No. 33396-29-1
Erythromycin A enol ether ( —— )
Catalog No. M27430 CAS No. 33396-29-1
Erythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 246 | Get Quote |
|
10MG | 357 | Get Quote |
|
25MG | 597 | Get Quote |
|
50MG | 851 | Get Quote |
|
100MG | 1152 | Get Quote |
|
500MG | 2313 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameErythromycin A enol ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionErythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.
-
DescriptionErythromycin A enol ether is a degradation product of Erythromycin A which is a macrolide antibiotic.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number33396-29-1
-
Formula Weight715.9
-
Molecular FormulaC37H65NO12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO([C@H]1[C@]2(C)OC(=C(C)C2)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@@H]1C)[C@H]4[C@H](O)[C@@H](N(C)C)C[C@@H](C)O4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen X, et al. Cyanin Chloride Inhibits Hyperbaric Pressure-Induced Decrease of Intracellular Glutamate-Aspartate Transporter in Rat Retinal Müller Cells. J Ophthalmol. 2018;2018:6128470.
molnova catalog
related products
-
DL-α-Hydroxyglutaric...
DL-α-Hydroxyglutaric acid disodium salt is an α -hydroxyacid formed from the hydrolysis of (R) -5-oxy-2-tetrahydrofuran carboxylic acid, which is overproduced in human neurometabolic disease D-α -hydroxyglutaric uria. ?
-
Morusin
Morusin possesses antitumor effects of cell lines including HT-29, A549, MCF-7 and MDA-MB-231, through suppressing STAT3 and NFκB attenuation mediated apoptosis induction.
-
FFAGLDD
FFAGLDD is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release.